Cardiovascular Research Institute.
Lung Biology Center, and.
Am J Respir Cell Mol Biol. 2020 Oct;63(4):424-435. doi: 10.1165/rcmb.2020-0182TR.
In pathological fibrosis, aberrant tissue remodeling with excess extracellular matrix leads to organ dysfunction and eventual morbidity. Diseases of fibrosis create significant global health and economic burdens and are often deadly. Although fibrosis has traditionally been thought of as an irreversible process, a growing body of evidence demonstrates that organ fibrosis can reverse in certain circumstances, especially if an underlying cause of injury can be removed. This body of evidence has uncovered more and more contributors to persistent and nonresolving tissue fibrosis. Here, we review the present knowledge on resolution of organ fibrosis and restoration of near-normal tissue architecture. We emphasize three critical areas of tissue homeostasis that are necessary for fibrosis resolution, namely, the elimination of matrix-producing cells, the clearance of excess matrix, and the regeneration of normal tissue constituents. In so doing, we also highlight how profibrotic pathways interact with one another and where there may be therapeutic opportunities to intervene and remediate pathological persistent fibrosis.
在病理性纤维化中,异常的组织重塑伴有细胞外基质的过度积累,导致器官功能障碍和最终的发病率。纤维化疾病给全球健康和经济带来了巨大的负担,而且往往是致命的。尽管纤维化传统上被认为是一个不可逆转的过程,但越来越多的证据表明,在某些情况下,器官纤维化可以逆转,特别是如果能去除损伤的根本原因。这些证据揭示了越来越多的导致持续和不可解决的组织纤维化的因素。在这里,我们回顾了关于器官纤维化消退和恢复接近正常组织结构的现有知识。我们强调了组织动态平衡的三个关键领域,这对于纤维化消退是必要的,即消除产生基质的细胞、清除多余的基质以及再生正常的组织成分。这样做的同时,我们还强调了促纤维化途径是如何相互作用的,以及在哪些地方可能存在治疗干预和纠正病理性持续纤维化的机会。